Type 2 diabetes is a common condition that accounts for significant morbidity and mortality because it is a major cardiovascular risk factor. It is now recognized as part of the metabolic syndrome. Given the frequency of vascular complications in patients with type 2 diabetes, antihypertensive management is of paramount importance. Many studies of different antihypertensive agents have been performed, and there are now abundant data regarding the role of calcium channel blocking agents, beta blocking agents, angiotensin-converting enzyme inhibitors, and angiotensin receptor blocking agents. This article reviews current guidelines for selecting appropriate antihypertensive agents for the treatment of hypertension in patients with diabetes.
|Original language||English (US)|
|Number of pages||9|
|Journal||Advanced Studies in Medicine|
|State||Published - Jun 1 2003|
ASJC Scopus subject areas